Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 17/20 | 1.00 |
| ▸ | HDAC3 | O15379 | 10/20 | 1.00 |
| ▸ | HDAC8 | Q9BY41 | 10/20 | 1.00 |
| ▸ | HDAC6 | Q9UBN7 | 10/20 | 1.00 |
| ▸ | HDAC4 | P56524 | 8/20 | 1.00 |
| ▸ | HDAC2 | Q92769 | 8/20 | 1.00 |
| ▸ | HDAC7 | Q8WUI4 | 6/20 | 1.00 |
| ▸ | HDAC10 | Q969S8 | 6/20 | 1.00 |
| ▸ | HDAC11 | Q96DB2 | 6/20 | 1.00 |
| ▸ | HDAC9 | Q9UKV0 | 6/20 | 1.00 |
| ▸ | HDAC5 | Q9UQL6 | 6/20 | 1.00 |
| ▸ | NCOR2 | Q9Y618 | 2/20 | 0.61 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ar-42 SCHEMBL675409 | 1.00 | HDAC1 (1.00) | HDAC1HDAC3HDAC8HDAC6HDAC4 | |
| Ar-42 SCHEMBL31140841 | 1.00 | HDAC1 (1.00) | HDAC1HDAC3HDAC8HDAC6HDAC4 | |
| SCHEMBL676825 | 0.89 | HDAC1 (0.80) | HDAC1HDAC3HDAC8HDAC6HDAC4 | |
| SCHEMBL3816907 | 0.87 | HDAC1 (0.76) | HDAC1HDAC3HDAC8HDAC6HDAC4 | |
| SCHEMBL2018982 | 0.86 | HDAC1 (0.76) | HDAC1HDAC3HDAC8HDAC6HDAC4 | |
| SCHEMBL14933783 | 0.85 | HDAC1 (0.74) | HDAC1HDAC3HDAC8HDAC6HDAC4 | |
| SCHEMBL675363 | 0.85 | HDAC1 (0.74) | HDAC1HDAC3HDAC8HDAC6HDAC4 | |
| SCHEMBL12681975 | 0.85 | HDAC1 (0.72) | HDAC1HDAC3HDAC8HDAC6HDAC4 | |
| SCHEMBL10343708 | 0.85 | HDAC1 (0.72) | HDAC1HDAC3HDAC8HDAC6HDAC4 | |
| SCHEMBL28317430 | 0.84 | HDAC1 (0.72) | HDAC1HDAC3HDAC8HDAC6HDAC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2306 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116209439-B | Cereblon protein modulators | Saint Jude Children's Research Hospital Ltd. (US) | 2026-05-26 | — | — | CN | claimed |
| WO-2026107052-A1 | COMBINATION TREATMENTS USING EPIGENETIC INHIBITION AND SYNGRI-MEDIATED FRATAXIN EXPRESSION | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. (US) | 2026-05-21 | — | — | WO | claimed |
| US-20260125650-A1 | METHODS AND COMPOSITIONS FOR GENERATING HEPATOCYTES | TRAILHEAD BIOSYSTEMS INC (US) | 2026-05-07 | — | — | US | claimed |
| EP-3985750-B1 | LIGHT-EMITTING DEVICE AND APPARATUS INCLUDING THE SAME | SAMSUNG DISPLAY CO LTD (KR) | 2026-04-29 | — | — | EP | claimed |
| US-12615960-B2 | Organic light-emitting device | SFC CO., LTD (KR) | 2026-04-28 | — | — | US | claimed |
| US-20260108619-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2026-04-23 | — | — | US | claimed |
| EP-4728537-A1 | SYNTHESIS AND INTEGRATION OF NOBLE GAS RADIOISOTOPE POWER SYSTEMS | The Charles Stark Draper Laboratory, Inc. (US) | 2026-04-22 | — | — | EP | claimed |
| EP-4720316-A2 | NON-VIRAL CELL ENGINEERING | Arsenal Biosciences, Inc. (US) | 2026-04-08 | — | — | EP | claimed |
| US-20260096340-A1 | An Electroluminescent Device Comprising an Anode Layer, a Cathode Layer, a First Emission Layer, a Hole Injection Layer and a First Hole Transport Layer that Comprises a Compound Containing a Metal | NOVALED GMBH (DE) | 2026-04-02 | — | — | US | claimed |
| US-12576124-B2 | Formulation of a conjugate of a tubulysin analog to a cell-binding molecule | HANGZHOU DAC BIOTECH CO., LTD (CN) | 2026-03-17 | — | — | US | claimed |
| US-20170095436-A1 | METHODS FOR TREATING MENDELIAN DISORDERS OF THE EPIGENETIC MACHINERY | THE JOHNS HOPKINS UNIVERSITY (US) | 2017-04-06 | — | — | US | claimed |
| WO-2017048193-A1 | DERIVATION OF LIVER ORGANOIDS FROM HUMAN PLURIPOTENT STEM CELLS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (A*STAR) (SG) | 2017-03-23 | — | — | WO | claimed |
| US-20170056336-A1 | CO-TARGETING ANDROGEN RECEPTOR SPLICE VARIANTS AND MTOR SIGNALING PATHWAY FOR THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2017-03-02 | — | — | US | claimed |
| US-20160346287-A1 | METHOD OF TREATING VIRAL INFECTIONS | EPIPHANY BIOSCIENCES, INC. | 2016-12-01 | — | — | US | claimed |
| US-20160068466-A1 | ESTER DERIVATIVES OF ANDROGEN RECEPTOR MODULATORS AND METHODS FOR THEIR USE | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2016-03-10 | — | — | US | claimed |
| WO-2016030345-A1 | PRODUCTS FOR THE TREATMENT AND PREVENTION OF NEUROLOGICAL DISORDERS COURSING WITH A COGNITION DEFICIT OR IMPAIRMENT, AND OF NEURODEGENERATIVE DISEASES | FUNDACIÓN PARA LA INVESTIGACIÓN MÉDICA APLICADA (ES) | 2016-03-03 | — | — | WO | claimed |
| WO-2015184260-A2 | METHODS FOR TREATING MENDELIAN DISORDERS OF THE EPIGENETIC MACHINERY | THE JOHNS HOPKINS UNIVERSITY (US) | 2015-12-03 | — | — | WO | claimed |
| WO-2015184279-A1 | COMPOSITIONS AND METHODS FOR TREATING KABUKI SYNDROME AND RELATED DISORDERS | THE JOHNS HOPKINS UNIVERSITY (US) | 2015-12-03 | — | — | WO | claimed |
| US-9173939-B2 | Ester derivatives of androgen receptor modulators and methods for their use | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2015-11-03 | — | — | US | claimed |
| US-20150050241-A1 | METHOD OF TREATING VIRAL INFECTIONS | EPIPHANY BIOSCIENCES, INC. | 2015-02-19 | — | — | US | claimed |